RxDoctor Payments Data

Hunter Iacovetti

Physician Assistant · Amityville, NYNPI 1649872771

Payments from drug & device makers

$3,370in general payments, 2019–2025

Across 134 payments — averaging $25.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$570
  • Novo Nordisk$334
  • Otsuka America Pharmaceutical, Inc.$292
  • Sumitomo Pharma America, Inc.$253
  • Corium, LLC$225
  • GSK$217
  • plus $1K from 29 others

What the payments were for

  • Food & beverage$3,370100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,370 in reported general payments places this provider in the 90th percentile of 11,358 physician assistant providers in New York.

See all physician assistant providers in New York

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban83$63,336
OzempicSemaglutide42$45,590
RybelsusSemaglutide24$34,564
JardianceEmpagliflozin20$19,865
XareltoRivaroxaban14$13,816
GemtesaVibegron14$12,684
JanuviaSitagliptin Phosphate12$6,777
Metoprolol Succinate159$1,901
Levothyroxine Sodium148$1,820
Colesevelam Hcl12$1,637
Calcitonin-SalmonCalcitonin,salmon,synthetic27$1,627
Gabapentin105$1,164
Losartan Potassium107$1,099
Pantoprazole Sodium93$1,061
Memantine Hcl ErMemantine Hcl17$1,012

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$334$80,15466 claims
PfizerEliquis$24$63,33683 claims
Johnson & JohnsonXarelto$64$13,81614 claims
Sumitomo Pharma America, Inc.Gemtesa$253$12,68414 claims
MerckJanuvia$114$6,77712 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 11,358 physician assistant providers in New York.

Other physician assistant in Amityville

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →